左心房機能は,多動性心筋症候群の患者における運動不耐性の強い予測因子である
Mengdi Yu1, Lutong Pu1, Yaxin Zhou2
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in cardiovascular medicine
|February 19, 2026
まとめ
左心房 (LA) 機能不全,特に減少したLAストレンは,多動性心筋病 (HCM) の患者の運動能力を制限する重要な要因です. この発見は,HCM患者の運動耐性を改善するための重要なターゲットとしてLA機能を強調しています.
科学分野:
- 心臓病学 心臓病学
- 心血管画像検査 (CVDI) について
- 運動生理学 運動生理学
背景:
- ハイパルトロフィック心筋症 (HCM) はしばしば運動不耐症を引き起こす.
- HCM患者の運動能力に影響を与える主な要因は,完全に理解されていません.
研究 の 目的:
- HCM患者における運動不耐性を評価する.
- 運動能力と臨床/イメージングの特徴との関係を調査し,左心房 (LA) 機能に焦点を当てます.
主な方法:
- 成人HCM患者の潜在的なコホートに関する遡及的分析.
- 標準化された心肺運動検査 (CPET) と3.0T心磁気共振 (CMR) を実施した.
- 運動能力 (ピーク酸素摂取量,ピークVO2) とLA機能 (直径,体積,ストレート) は,それぞれCPETとCMRを用いて評価されました. 線形回帰では,運動能力の決定要因が特定されました.
主要な成果:
- 120人のHCM患者のうち77.8%が運動耐性が低下した (ピークVO2 <80%が予測された).
- 低ピークVO2は,高齢,女性の性別,より大きなLAサイズ,および減少したLA株と相関しています.
- 左心室 (LV) パラメータと流出管の圧力グラデーションはピークVO2と有意に相関していない. LA貯水槽株は,LAのサイズと量を上回るピークVO2 (β=0.275,P<0.001) の独立した予測因子として登場しました.
結論:
- 減圧によって示される左心房 (LA) 機能障害は,ハイパートロフィック心筋病 (HCM) の運動能力の低下を独立して予測します.
- LA貯水槽菌株は,HCM患者における運動能力の有意な独立した予測因子である.
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
540
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Cardiomyopathy V: Interprofessional Care
493
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
626
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
626
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Mitral Regurgitation I: Introduction
654
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
654


